Header Logo

Connection

Mayer Davidson to Insulin

This is a "connection" page, showing publications Mayer Davidson has written about Insulin.
Connection Strength

9.795
  1. Real-world evidence for computerized insulin dose-adjustment algorithms in the effective use of continuous glucose monitoring by primary care clinicians. Diabetes Obes Metab. 2024 Aug; 26(8):3475-3477.
    View in: PubMed
    Score: 0.832
  2. A simplified straightforward protocol for the use of U-500 regular insulin. Diabetes Obes Metab. 2023 02; 25(2):634-636.
    View in: PubMed
    Score: 0.745
  3. Second-generation basal insulins to initiate insulin therapy in type 2 diabetes: A need for clinical evidence before incurring increased costs. Diabetes Obes Metab. 2020 05; 22(5):719-721.
    View in: PubMed
    Score: 0.620
  4. Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetes. Ann Intern Med. 2019 04 16; 170(8):JC39.
    View in: PubMed
    Score: 0.582
  5. Delayed response to an injection of U-500 regular insulin is not rare. J Diabetes. 2019 Jul; 11(7):519-521.
    View in: PubMed
    Score: 0.580
  6. Response to comment on Grunberger "insulin analogs-are they worth it? Yes!" Diabetes Care 2014;37:1767-1770 and Davidson "insulin analogs-is there a compelling case to use them? No!" Diabetes Care 2014;37:1771-1774. Diabetes Care. 2014 Oct; 37(10):e231.
    View in: PubMed
    Score: 0.425
  7. Insulin analogs--is there a compelling case to use them? No! Diabetes Care. 2014 Jun; 37(6):1771-4.
    View in: PubMed
    Score: 0.415
  8. Self-mixed/split insulin regimen: a serious omission in the ADA/EASD position statement. Diabetes Care. 2014; 37(1):3-4.
    View in: PubMed
    Score: 0.403
  9. Comment on: Tam et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 2012;35:1605-1610. Diabetes Care. 2013 Jan; 36(1):e10.
    View in: PubMed
    Score: 0.376
  10. A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure. Endocr Pract. 2011 May-Jun; 17(3):395-403.
    View in: PubMed
    Score: 0.335
  11. U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients. Diabetes Care. 2010 Feb; 33(2):281-3.
    View in: PubMed
    Score: 0.303
  12. Pro's and con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation. Curr Opin Endocrinol Diabetes Obes. 2009 Apr; 16(2):107-12.
    View in: PubMed
    Score: 0.290
  13. No need for the needle (at first). Diabetes Care. 2008 Oct; 31(10):2070-1.
    View in: PubMed
    Score: 0.280
  14. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract. 2007 Jul-Aug; 13(4):427-8.
    View in: PubMed
    Score: 0.257
  15. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients. Diabetes Care. 2006 Nov; 29(11):2504-5.
    View in: PubMed
    Score: 0.245
  16. Starting insulin therapy in type 2 diabetic patients: does it really matter how? Diabetes Care. 2005 Feb; 28(2):494-5.
    View in: PubMed
    Score: 0.217
  17. Early insulin therapy for type 2 diabetic patients: more cost than benefit. Diabetes Care. 2005 Jan; 28(1):222-4.
    View in: PubMed
    Score: 0.216
  18. Indirect support for the use of supplemental insulin in hospitalized insulin-requiring diabetic patients. Diabetes Care. 2004 Sep; 27(9):2260-1.
    View in: PubMed
    Score: 0.211
  19. Twice-Daily NPH or mixture insulins versus triple therapy: apples versus oranges: response to Poulsen et al. Diabetes Care. 2004 Jul; 27(7):1846; author reply 1847-8.
    View in: PubMed
    Score: 0.209
  20. Comment on Aleppo et al. The Effect of Discontinuing Continuous Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737. Diabetes Care. 2022 04 01; 45(4):e84.
    View in: PubMed
    Score: 0.179
  21. Established therapies for diabetes mellitus. Curr Med Res Opin. 2002; 18 Suppl 1:s13-21.
    View in: PubMed
    Score: 0.176
  22. Effect of data management on a central server on HbA1c levels in insulin-requiring patients. Diabetes Care. 2000 May; 23(5):706-7.
    View in: PubMed
    Score: 0.156
  23. Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections. JAMA. 2017 01 24; 317(4):363-364.
    View in: PubMed
    Score: 0.125
  24. Effect of tumor necrosis factor-alpha on basal and insulin-stimulated glucose transport in cultured muscle and fat cells. Metabolism. 1996 Sep; 45(9):1089-94.
    View in: PubMed
    Score: 0.121
  25. Treatment of poorly controlled type 2 diabetes. Compr Ther. 1994; 20(6):321-5.
    View in: PubMed
    Score: 0.101
  26. Protein and fat effects on glucose responses and insulin requirements in subjects with insulin-dependent diabetes mellitus. Am J Clin Nutr. 1993 Oct; 58(4):555-60.
    View in: PubMed
    Score: 0.099
  27. Successful treatment of unusual case of brittle diabetes with sulfated beef insulin. Diabetes Care. 1991 Nov; 14(11):1109-10.
    View in: PubMed
    Score: 0.087
  28. Insulin plus a sulfonylurea agent for treating type 2 diabetes. Ann Intern Med. 1991 Jul 01; 115(1):45-53.
    View in: PubMed
    Score: 0.085
  29. Modern management of the insulin-requiring patient. Compr Ther. 1990 Jul; 16(7):49-55.
    View in: PubMed
    Score: 0.079
  30. Inhibition of sleep-induced growth hormone secretion: no effect on diabetic control. Diabetes Care. 1990 Jul; 13(7):813-4.
    View in: PubMed
    Score: 0.079
  31. Moderate insulinopenia can cause insulin antagonism. Diabetes Res Clin Pract. 1987 Nov-Dec; 3(6):319-26.
    View in: PubMed
    Score: 0.066
  32. Inverse relationship of metabolic clearance rate of insulin to body mass index. Metabolism. 1987 Mar; 36(3):219-22.
    View in: PubMed
    Score: 0.063
  33. Futility of self-monitoring of blood glucose without algorithms for adjusting insulin doses. Diabetes Care. 1986 Mar-Apr; 9(2):209-10.
    View in: PubMed
    Score: 0.059
  34. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Welschen et al. and Kleefstra et al. Diabetes Care. 2005 Oct; 28(10):2597; author reply 2597-8.
    View in: PubMed
    Score: 0.057
  35. Hyperthyroid Graves' disease causes insulin antagonism. J Clin Endocrinol Metab. 1985 May; 60(5):1038-41.
    View in: PubMed
    Score: 0.055
  36. Insulin binding and action in isolated rat hepatocytes: effect of obesity and fasting. Am J Physiol. 1982 Sep; 243(3):E240-5.
    View in: PubMed
    Score: 0.046
  37. Primary insulin antagonism of glucose transport in muscle from the older-obese rat. Metabolism. 1978 Dec; 27(12 Suppl 2):1994-2005.
    View in: PubMed
    Score: 0.035
  38. Treatment of non-insulin-dependent diabetes mellitus. Mayo Clin Proc. 1997 Jan; 72(1):92.
    View in: PubMed
    Score: 0.031
  39. Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: a new use for an old friend. J Clin Endocrinol Metab. 1996 Jul; 81(7):2423-7.
    View in: PubMed
    Score: 0.030
  40. Effect of protein intake and dialysis on the abnormal growth hormone, glucose, and insulin homeostasis in uremia. Metabolism. 1976 Apr; 25(4):455-64.
    View in: PubMed
    Score: 0.029
  41. Dexamethasone-induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation. Metabolism. 1996 Jan; 45(1):92-100.
    View in: PubMed
    Score: 0.029
  42. Insulin sensitivity of the large human adipocyte in vitro. Diabetes. 1975 Dec; 24(12):1086-93.
    View in: PubMed
    Score: 0.029
  43. Phenobarbital treatment enhances insulin-mediated glucose metabolism and improves lipid metabolism in the diabetic rat. Metabolism. 1994 Mar; 43(3):348-56.
    View in: PubMed
    Score: 0.025
  44. The challenge of blood glucose management in diabetic patients receiving enteral or parenteral nutrition. JPEN J Parenter Enteral Nutr. 1993 Jan-Feb; 17(1):1-2.
    View in: PubMed
    Score: 0.024
  45. Rational use of sulfonylureas. Postgrad Med. 1992 Aug; 92(2):69-70, 73-6, 79-85.
    View in: PubMed
    Score: 0.023
  46. Effect of obesity on insulin sensitivity on human adipose tissue. Diabetes. 1972 Jan; 21(1):6-12.
    View in: PubMed
    Score: 0.022
  47. Metabolic and thermal responses to Piromen in man. J Clin Endocrinol Metab. 1971 Feb; 32(2):179-87.
    View in: PubMed
    Score: 0.021
  48. The variability in the action of unmodified insulin is more dependent on changes in tissue insulin sensitivity than on insulin absorption. Diabet Med. 1988 Oct; 5(7):662-6.
    View in: PubMed
    Score: 0.018
  49. Use oral hypoglycemics with caution...but keep caution in context. Geriatrics. 1988 Aug; 43(8):83-4.
    View in: PubMed
    Score: 0.017
  50. Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats. Diabetes. 1988 Jul; 37(7):885-90.
    View in: PubMed
    Score: 0.017
  51. Peripheral and hepatic insulin antagonism in hyperthyroidism. J Clin Endocrinol Metab. 1988 Mar; 66(3):565-9.
    View in: PubMed
    Score: 0.017
  52. Exogenous insulin therapy slows weight loss in type 2 diabetic patients. Int J Obes. 1988; 12(2):149-55.
    View in: PubMed
    Score: 0.017
  53. Effect of storage on action of NPH and regular insulin mixtures. Diabetes Care. 1987 Nov-Dec; 10(6):799-800.
    View in: PubMed
    Score: 0.016
  54. Failure of synalbumin to exhibit insulin antagonism in vivo. Diabetes. 1967 Jun; 16(6):386-94.
    View in: PubMed
    Score: 0.016
  55. Update on therapy of diabetes mellitus: diet, sulfonylurea agents, and insulin. Mt Sinai J Med. 1987 Mar; 54(3):199-210.
    View in: PubMed
    Score: 0.016
  56. Pathogenesis of type 2 diabetes mellitus: an interpretation of current data. Am J Med Sci. 1986 Jul; 292(1):35-9.
    View in: PubMed
    Score: 0.015
  57. Insulin secretion and action in the hyperthyroid rat. Horm Metab Res. 1985 Aug; 17(8):383-6.
    View in: PubMed
    Score: 0.014
  58. Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status. West J Med. 1985 Feb; 142(2):219-29.
    View in: PubMed
    Score: 0.014
  59. Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care. 1983 Jul-Aug; 6(4):319-27.
    View in: PubMed
    Score: 0.012
  60. Diabetes in the elderly: diagnosis and treatment. Hosp Pract (Hosp Ed). 1982 Apr; 17(4):113-20, 125, 128-9.
    View in: PubMed
    Score: 0.011
  61. Hepatic effects of glucose and insulin independent of cyclic nucleotide changes. Acta Diabetol Lat. 1981 Oct-Dec; 18(4):297-310.
    View in: PubMed
    Score: 0.011
  62. Perioperative management of diabetes mellitus. Anesthesiology. 1981 Aug; 55(2):104-9.
    View in: PubMed
    Score: 0.011
  63. The case for routinely testing the first-voided urine specimen. Diabetes Care. 1981 May-Jun; 4(3):443-4.
    View in: PubMed
    Score: 0.010
  64. Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes. 2001 May; 50(5):1186-92.
    View in: PubMed
    Score: 0.010
  65. Role of ketogenesis in urinary sodium excretion: elucidation by nicotinic acid administration during fasting. J Clin Endocrinol Metab. 1979 Dec; 49(6):818-23.
    View in: PubMed
    Score: 0.009
  66. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism. 1979 Jun; 28(6):688-705.
    View in: PubMed
    Score: 0.009
  67. The case for control in diabetes mellitus. West J Med. 1978 Sep; 129(3):193-200.
    View in: PubMed
    Score: 0.009
  68. Metabolic studies in familial partial lipodystrophy of the lower trunk and extremities. Diabetologia. 1975 Dec; 11(6):561-8.
    View in: PubMed
    Score: 0.007
  69. Growth hormone responses to fructose in diabetes mellitus. Acta Endocrinol (Copenh). 1974 Mar; 75(3):497-502.
    View in: PubMed
    Score: 0.006
  70. Role of growth hormone in the alteration of carbohydrate metabolism induced by oral contraceptive agents. J Clin Endocrinol Metab. 1973 Feb; 36(2):246-55.
    View in: PubMed
    Score: 0.006
  71. The effect of potassium chloride infusion on insulin secretion in vivo. Horm Metab Res. 1972 Mar; 4(2):64-8.
    View in: PubMed
    Score: 0.006
  72. Studies on the mechanism of pentobarbital-induced glucose intolerance. Horm Metab Res. 1971 Jul; 3(4):243-7.
    View in: PubMed
    Score: 0.005
  73. Role of synalbumin insulin antagonist in pathogenesis of diabetes mellitus. Metabolism. 1970 Sep; 19(9):668-86.
    View in: PubMed
    Score: 0.005
  74. Effects of reserpine on biological clocks for metabolic fuels during starvation in man. Diabetes. 1968; 17:312.
    View in: PubMed
    Score: 0.004
  75. Insulin antagonism is not a primary abnormality of amyotrophic lateral sclerois but is related to disease severity. J Clin Endocrinol Metab. 1986 Jul; 63(1):41-6.
    View in: PubMed
    Score: 0.004
  76. Simple solution to problem of biostator-induced insulin aggregation. Diabetes Care. 1986 Jul-Aug; 9(4):356-8.
    View in: PubMed
    Score: 0.004
  77. Diabetes mellitus. Ann Intern Med. 1982 May; 96(5):635-49.
    View in: PubMed
    Score: 0.003
  78. Obesity: a serious symptom. Ann Intern Med. 1972 Nov; 77(5):779-95.
    View in: PubMed
    Score: 0.001
  79. Studies of substrate regulation in fasting. I. Evidence for central regulation of lipolysis by plasma glucose mediated by the sympathetic nervous system. Diabetes. 1967 Aug; 16(8):576-89.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.